Canada markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5900-0.1800 (-6.50%)
At close: 04:00PM EDT
2.5900 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
87
95
156
114,089
0
Operating Expenses
Research Development
214,935
242,914
256,387
220,176
192,987
Selling General and Administrative
70,056
71,673
79,305
74,105
65,256
Total Operating Expenses
284,991
314,587
335,692
294,281
258,243
Operating Income or Loss
-284,904
-314,492
-335,536
-180,192
-258,243
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
-29,074
-31,080
-9,444
-3,573
-67,302
Income Before Tax
-292,297
-327,265
-340,414
-182,051
-316,381
Income Tax Expense
-
-
-
0
0
Income from Continuing Operations
-292,297
-327,265
-340,414
-182,051
-316,381
Net Income
-292,297
-327,265
-340,414
-182,051
-316,381
Net Income available to common shareholders
-292,297
-327,265
-340,414
-182,051
-316,381
Basic EPS
-2.20
-2.09
-2.38
-1.34
-2.63
Diluted EPS
-2.20
-2.09
-2.38
-1.34
-2.63
Basic Average Shares
150,856
156,932
143,147
135,820
120,370
Diluted Average Shares
150,856
156,932
143,147
135,820
120,370